Shandong Boan Biotechnology Co., Ltd. has received marketing approval from China’s National Medical Products Administration for Boyouping® (Dulaglutide Injection), a biosimilar to Trulicity ...

Injecting trulicity dulaglutide is simple, but proper use is vital for the best results. Always inject into a clean area on the abdomen, thigh, or upper arm, rotating the injection site to avoid ...

Launched in 2015, Trulicity is making an impact in the competitive GLP-1 market, much of its appeal derived from it more convenient weekly injection, rather than the daily jab needed for Victoza.

Two doses of Eli Lilly’s dulaglutide (4.5 mg and 3.0 mg), as well as Trulicity® (dulaglutide) 1.5 mg, provided significantly better blood sugar control with weight benefits for those with type ...

The GIP/GLP-1 dual agonist tirzepatide (Mounjaro) showed cardiovascular protective benefits over dulaglutide (Trulicity) in the phase III SURPASS-CVOT trial of diabetes patients with heart disease ...

INDIANAPOLIS, June 4, 2022 /PRNewswire/ -- In the phase 3 AWARD-PEDS clinical trial from Eli Lilly and Company (NYSE: LLY), Trulicity ® (dulaglutide) (at 0.75 mg and 1.5 mg doses) led to superior ...

Novo Nordisk is going all in on Ozempic, its once-weekly GLP-1 injection for diabetes that was approved by the FDA in December 2017. The Danish pharma has shifted marketing spend away from Victoza, ...

Eli Lilly's Mounjaro matched Trulicity in heart outcomes and showed added benefits on A1C, weight, kidney function, and mortality in a major trial.

The ~5-year trial involved 13,299 patients with type 2 diabetes and established atherosclerotic cardiovascular disease, comparing once-weekly Mounjaro against Trulicity (dulaglutide), which is ...